This mentored career development award is intended to support an early career investigator (fellow, assistant professor) who demonstrates a clear track record and commitment to developing an independent research career in pediatric rheumatology.
3 Awards
$366,000 per award
LOI Deadline: January 20, 2026
Application Deadline: March 2, 2026
When reviewers evaluate CARRA applications, they tend to look for:
✔ 1. Direct Relevance to Pediatric Rheumatic Disease
Applications must address a specific clinical or translational question in diseases such as juvenile idiopathic arthritis, pediatric lupus, dermatomyositis, scleroderma, or vasculitides — ideally leveraging CARRA’s registry or biorepository. CARRA
✔ 2. Use of CARRA Registry or Collaborative Infrastructure
Projects that use existing registry data or biosamples (e.g., for comparative effectiveness research) often score well because they align with CARRA’s mission to generate real-world evidence. CARRA
✔ 3. Clear, Feasible Research Plan
A well-scoped design with realistic methods and defined milestones boosts competitiveness, especially for pilot and small grant applications. CARRA
✔ 4. Investigator Qualifications & Mentorship
For career development awards, evidence of preparation (publications, training) and strong mentorship are crucial predictors of success. Research at UCalgary
✔ 5. Collaborative and Multidisciplinary Approach
Grants that involve multiple investigators or disciplines — particularly those that show how team science will yield deeper insights — are viewed favorably. CARRA
✔ 6. Potential to Generate Preliminary Data for Larger Grants
Projects that intend to seed future NIH, PCORI, or foundation funding are attractive since they amplify CARRA’s strategic impact. Arthritis Foundation
✔ Align aims with CARRA’s mission to improve outcomes for children with rheumatic diseases. CARRA
✔ Integrate registry data when possible to strengthen feasibility and impact. CARRA
✔ Define clear deliverables (e.g., data analysis plans, consensus tools, pilot safety/efficacy measures). CARRA
✔ Engage collaborators early — multicenter participation resonates with CARRA’s collaborative ethos. CARRA
✔ Highlight career relevance for mentored awards, with strong letters from mentors. Research at UCalgary
✔ Budget realistically for the scope and period of the award. CARRA
| Award Type | Target | Focus | Typical Support |
|---|---|---|---|
| Mentored Career Development Award | Early independent investigators | Career phenotype in pediatric rheumatology | ~$375,000 (3 yrs) Rheumatology Research Foundation |
| Fellows Grant | Trainee researchers | Project support during fellowship | ~$25,000 (1 yr) Rheumatology Research Foundation |
| Small Grant | Investigators | Pilot or focused research | ~$50,000 (1 yr) Rheumatology Research Foundation |
| Clinical Management JIA Grant | Clinician scientists | Registry-based decision research | ~$100,000 (2 yrs) Rheumatology Research Foundation |
| Advancing Biosample Collection | Translational research | Biorepository expansion | ~$50,000 (2 yrs) Rheumatology Research Foundation |
| Team Science / Large Grants | Collaborative teams | Planning or larger cross-center work | ~$100,000+ (2 yrs) Rheumatology Research Foundation |
| Travel Awards | Early investigators | Conference presentations | ~$2,000 Rheumatology Research Foundation |
| CARRA-PReS Collaborative Award | Early career international | Collaborative pilot work | ~€50,000 (2 yrs) |
• The project principal investigator (PI) must be a CARRA member in good standing (up to date on membership dues and member profile is current and accurate).
• Applicants must hold an MD and must be at the instructor or assistant professor or equivalent level. Third-year fellows with offers of faculty positions are also eligible.
• The following current CARRA members are eligible to serve as PIs on this award:
o Pediatric rheumatologists • Current or past MCDA grant awardees are not eligible to apply.
• Previous and current CARRA awardees who wish to submit new grant applications must be up to date on all award deliverables.
Sponsor Institute/Organizations: Childhood Arthritis and Rheumatology Research Alliance (CARRA)
Sponsor Type: Corporate/Non-Profit
Address: 1050 Connecticut Avenue, NW, Suite 500 Washington, DC 20036
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 02, 2026
Mar 02, 2026
$366,000
Affiliation: Childhood Arthritis and Rheumatology Research Alliance (CARRA)
Address: 1050 Connecticut Avenue, NW, Suite 500 Washington, DC 20036
Website URL: https://carragroup.org/research/grant-opportunities/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.